Emerald Health Therapeutics, Inc. has launched SYNC Tabs, a naturally-flavored ingestible offering consumers a controlled 10 mg THC dose with predictable onset and offset.
This product line expands Emerald’s offering under its SYNC Wellness brand and is the second of Emerald's Defined Dose products. The tablets are available to consumers at licensed cannabis retailers and online in British Columbia, Manitoba and Newfoundland, with Alberta to follow.
Emerald's Cannabis 2.0 and 3.0 strategy focuses on leveraging science-based innovation to serve targeted consumer preferences. This differentiated new product line builds on Emerald's commitment to offering consumers defined dosing and predictable actions that let them control their cannabis consumption experience. SYNC Tabs are designed in a familiar tablet form that enables convenient yet discreet cannabis use.
With 10 mg of THC, SYNC Tabs offer consumers the measured stringency of Emerald's Defined Dose standard, dissolve under the tongue in about three minutes, and provide desired effects within 20 to 30 minutes. Offset is equally controlled, occurring within approximately 90 minutes of taking the tablet.
Designed to serve customers' use of cannabis for daily wellness routines, SYNC Tabs are sugar-free, gluten-free, vegan and come in two natural flavors, Cherry and Mint. Produced with 100-percent coconut-derived MCT oil, the products offer a sustainably-produced cannabis wellness option. Each pack contains 10 10-mg doses, offering 100 mg THC in total.
"Our product development efforts are centered on providing consumers with distinctive cannabis products offering controlled, predictable actions – with greater precision of dosing and the onset and offset of effects," said Riaz Bandali, president and CEO. "We have a talented product development team that is passionate about science and innovation. They are moving additional new product lines toward launches planned for the next few months and quarters, which we expect to start positively impacting our growth."